ZFunds
For Experts
About Us
Contact Us
Start a Conversation
Portfolio Management Services (PMS)
Compare Schemes
Square 64 - Multicap vs Valcreate Lifesciences and Specialty Opportunities
Benchmark
Download PDF
Square 64 - Multicap
Valcreate Lifesciences and Specialty Opportunities
Add Scheme
Growth of
₹1 Crore
Square 64 - Multicap
Valcreate Lifesciences and Specialty Opportunities
Since Inception
1Y
Return for the risk
3Y
1Y
3 yrs return
15%
20%
25%
Valcreate Lifesciences and Specialty Opportunities
19.3% • vol 20.7%
10%
20%
30%
Volatility • 3 yrs deviation
Overview
1 Month
5.13%
6.35%
6 Months
29.29%
17.95%
1 Year
14.37%
21.71%
3 Years
—
19.34%
5 Years
—
—
Since Inception
7.27%
19.34%
Fund Age
1 yr 10 mo
3 yrs 6 mo
AUM
₹108.4 Cr
₹18.73 Cr
Outerperformance
Alpha – 1 Year
9.65%
16.99%
Alpha – 3 Years
—
7.25%
Information Ratio – 3 Years
—
0.85
Risk Ratios
Volatility – 1 Year
30.58%
22.22%
Volatility – 3 Years
—
20.72%
Beta – 1 Year
1.41
0.87
Beta – 3 Years
—
0.89
Sharpe Ratio – 1 Year
0.40
0.75
Sharpe Ratio – 3 Years
—
0.85
Worst Rolling Year
—
—
Value at Worst Rolling Year
—
—
Deepest Drawdown
−25.30%
—
Recovery Period
Not yet recovered
—
Consistency
1-Year Rolling Windows Positive
—
—
Median Rolling Year
—
—
5-Year Rolling Windows Positive
—
—
Portfolio
Market-Cap Mix
—
—
Number of Stocks
—
—
Portfolio P/E
—
—
Top 5 Holdings
—
Sharda Cropchem Ltd · 11.13%
Kwality Pharmaceuticals Ltd · 5.72%
Sumitomo Chemical India Ltd · 5.72%
Vinati Organics Ltd · 5.51%
Rallis India Ltd · 5.34%
Top Sectors
—
—
Fees
Fixed Fee
—
2.50% / yr
Performance Fee / Plan
—
Fixed Plan
Exit Load (Y1 / Y2 / Y3)
—
0% / 0% / 0%
Let's start a
conversation
Compare this PMS against 3,000+ others with our research desk
Build a long-term portfolio around your goals, not a one-off buy
Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.
Start a conversation
Share a few details and an expert will reach out.
Zoom Call
Get a Call
Proceed
We will only use these details to contact you about this enquiry. No spam.